Development of cabozantinib for the treatment of prostate cancer

  • Ulka Vaishampayan
  • Core Evidence, April 2014, Taylor & Francis
  • DOI: 10.2147/ce.s48498

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.2147/ce.s48498